机构

• 上海药物研究所 [18]
• 西北高原生物研究所 [5]
• 上海营养与健康研究所 [5]
• 昆明植物研究所 [3]
• 昆明动物研究所 [3]
• 生态环境研究中心 [2]
• 更多

采集方式

• OAI收割 [44]
• iSwitch采集 [1]

内容类型

• 期刊论文 [44]
• 学位论文 [1]

发表日期

• 2023 [3]
• 2022 [7]
• 2021 [4]
• 2020 [5]
• 2019 [6]
• 2018 [5]
• 更多

学科主题

• Science & ... [3]
• Chemistry [2]
• Biochemist... [1]
• Cell Biolo... [1]
• Dentistry,... [1]
• Geriatrics... [1]
• 更多

筛选

浏览/检索结果: 共45条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 Saikosaponin D improves nonalcoholic fatty liver disease via gut microbiota-bile acid metabolism pathway 期刊论文  OAI收割 Food Science and Human Wellness, 2023 作者:  Li, Lan;  Yang, Shengye;  Liang, Xinyu;  Liu, Yameng;  Xu, Hualing   |  收藏  |  浏览/下载：45/0  |  提交时间：2024/03/26 Gut Microbiota  Non-alcoholic Fatty Liver Disease  Ssd  Bile Acids  Farnesoid x Receptor   Parabacteroides distasonis ameliorates hepatic fibrosis potentially via modulating intestinal bile acid metabolism and hepatocyte pyroptosis in male mice 期刊论文  OAI收割 NATURE COMMUNICATIONS, 2023, 卷号: 14, 期号: 1, 页码: 1829 作者:  Zhao,Qi;  Dai,Man-Yun;  Huang,Ruo-Yue;  Duan,Jing-Yi;  Zhang,Ting   |  收藏  |  浏览/下载：20/0  |  提交时间：2024/05/09 FATTY LIVER-DISEASE  INDUCED CHOLESTASIS  STELLATE CELLS  PROBIOTICS  PROTECTS  INFLAMMATION  APOPTOSIS  OBESITY  AXIS   Prebiotic-Based Nanoamorphous Atorvastatin Attenuates Nonalcoholic Fatty Liver Disease by Retrieving Gut and Liver Health 期刊论文  OAI收割 SMALL STRUCTURES, 2023, 页码: 2200312 作者:  Cui,Jin-Jin;  Li,Rui;  Ma,Xiao-Lei;  Yu,Hao-Yang;  Luo,Zhi-Gang   |  收藏  |  浏览/下载：16/0  |  提交时间：2024/07/30 atorvastatin  gut flora  nanoamorphous  nonalcoholic fatty liver disease  prebiotics  SOLID DISPERSIONS  STATIN USE  EFFICACY  STEATOHEPATITIS  FORMULATION  SAFETY  ABSORPTION  ACTIVATION  MICROBIOTA  CIRRHOSIS   Mineral metabolism and ferroptosis in non-alcoholic fatty liver diseases 期刊论文  OAI收割 BIOCHEMICAL PHARMACOLOGY, 2022, 卷号: 205, 页码: 13 作者:  Ma, Chenhui;  Han, Li;  Zhu, Zheying;  Pang, Cheng Heng;  Pan, Guoyu   |  收藏  |  浏览/下载：43/0  |  提交时间：2022/11/11 Mineral  Iron  Ferroptosis  Copper  Non-alcoholic fatty liver disease  Non-alcoholic steatohepatitis   Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD: A promising drug Potentilla discolor Bunge 期刊论文  OAI收割 ACTA PHARMACEUTICA SINICA B, 2022, 卷号: 12, 期号: 9, 页码: 3529-3547 作者:  Ji, Longshan;  Li, Qian;  He, Yong;  Zhang, Xin;  Zhou, Zhenhua   |  收藏  |  浏览/下载：25/0  |  提交时间：2022/12/13 Anti-inflammatory  Lipid metabolism  Insulin resistance  Endoplasmic reticulum stress  Intestinal microflora  Nonalcoholic fatty liver disease (NAFLD)  Traditional Chinese medicine  Acupuncture  Potentilla discolor Bunge (PDB)  Natural active compounds  Anti-oxidative   MicroRNA-379-5p regulates free cholesterol accumulation and relieves diet induced-liver damage in db/db mice via STAT1/HMGCS1 axis 期刊论文  OAI收割 Molecular biomedicine, 2022, 卷号: 3, 期号: 1, 页码: 25 作者:  Dong, Yunxia;  Yu, Chuwei;  Ma, Ningning;  Xu, Xiaoding;  Wu, Qian   |  收藏  |  浏览/下载：42/0  |  提交时间：2024/03/15 Cholesterol metabolism  HMGCS1  MiR-379-5p  Non-alcoholic fatty liver disease  STAT1   Caffeic acid phenethyl ester suppresses intestinal FXR signaling and ameliorates nonalcoholic fatty liver disease by inhibiting bacterial bile salt hydrolase activity 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2022, 页码: 12 作者:  Zhong, Xian-Chun;  Liu, Ya-Meng;  Gao, Xiao-Xia;  Krausz, Kristopher W.;  Niu, Bing   |  收藏  |  浏览/下载：36/0  |  提交时间：2022/08/16 nonalcoholic fatty liver disease  caffeic acid phenethyl ester  bile salt hydrolase  farnesoid X receptor  ceramide  gut microbiota   Characterization of microbiome and metabolite analyses in patients with metabolic associated fatty liver disease and type II diabetes mellitus 期刊论文  OAI收割 BMC MICROBIOLOGY, 2022, 卷号: 22 作者:  Yang, Qiuping;  Zhang, Leisheng;  Li, Qian;  Gu, Man;  Qu, Qiu   |  收藏  |  浏览/下载：52/0  |  提交时间：2022/05/16 Metabolic associated fatty liver disease (MAFLD)  Type II diabetes mellitus (T2DM)  Gut microbiota  Metabolome  Clinical diagnosis   Bile acid and receptors: biology and drug discovery for nonalcoholic fatty liver disease 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2022, 页码: 17 作者:  Jiao, Ting-ying;  Ma, Yuan-di;  Guo, Xiao-zhen;  Ye, Yun-fei;  Xie, Cen   |  收藏  |  浏览/下载：32/0  |  提交时间：2022/06/15 bile acids  nonalcoholic fatty liver disease  nonalcoholic steatohepatitis  drug target  Farnesoid X receptor  G protein-coupled bile acid receptor   Association between Metabolic Dysfunction-associated Fatty Liver Disease and Cognitive Impairment 期刊论文  OAI收割 JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2022, 页码: 8 作者:  Yu, Qiang;  He, Ruixin;  Jiang, Haowen;  Wu, Ji;  Xi, Zhifeng   |  收藏  |  浏览/下载：37/0  |  提交时间：2022/08/16 NHANES  Metabolic dysfunction-associated fatty liver disease  Nonalcoholic fatty liver disease  Cognitive dysfunction